Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

PLAGL2 (Pleomorphic adenoma gene-like 2)

Identity

Other namesFLJ23283
KIAA0198
Hugo PLAGL2
Location 20q11.21

DNA/RNA

 
  PLAGL2 exons and corresponding nucleotide numbers on each GenBank sequence database are shown in this table.
Description PLAGL2 (PLAG-Like 2; a PLAG family member; GenBank accession number AF006005) was identified by homology searches of the database of expressed sequence tags (ESTs) and sequence similarity to zinc-finger region of the human PLAGL1/LOT1/ZAC1 and PLAG1 proteins.

Protein

 
Description PLAGL2 protein consists of 496 amino acid residues, six C2H2-type zinc finger domains in its amino-terminal region (shown as brown in the figure), and a proline- and serine-rich carboxyl terminus (shown as blue).
Expression Northern analysis showed that the PLAGL2 mRNA is expressed in fetal kidney, liver, lung, and brain but not in adult tissues. However, PCR analysis showed that PLAGL2 is ubiquitously expressed in almost all adult and fetal human tissues, except for the relatively low level of expression observed in fetal brain.
Localisation Nuclear.
Function PLAGL2 can bind and activate human insulin-like growth factor II (IGF II) gene promoter; therefore, the oncogenic capacity of PLAGL2 may be mediated by activating the IGF-II mitogenic pathway. However, PLAGL2, possibly by association with HIF-1, may also have apoptotic role since it can activate Nip3 promoter and induce transcription in Balb/c3T3 fibroblasts and Neuro2a neuroblastoma cells, leading to apoptosis. PLAGL2 mRNA can be induced upon iron deficiency or hypoxia in mouse macrophage cell line RAW264.7, mouse erythroleukemia (MEL) cells, and Balb/c3T3 cells. In addition, PLAGL2 can also transactivate the surfactant protein-C (SP-C), a protein whose expression occurs principally in type II pneumocytes located in the distal lung alveolae. Additional data suggest that repression of the transactivating capacity of PLAGL2 may be directly related to sumoylation. Also, PLAGL2 protein is acetylated and activated by p300 and deacetylated and repressed by HDAC7, involving the lysine residues as the acetylation target. Therefore, it appears that the activity of PLAGL2 is tightly modulated by both sumoylation and acetylation, which may have opposite effects on their transactivation. Tip60 can modulate PLAGL2 function through both acetylation and inhibition of sumoylation, resulting in an enhanced PLAGL2-mediated transactivation. PLAGL2 can bind and stabilize (by preventing proteasomal degradation) Pirh2 dimer, a p53 inducible E3 ligase involved in the ubiquitination of p53. PLAGL2 can also regulate NCF2 gene expression through binding to the tumor necrosis factor (TNF)-alpha-responsive region of the NCF2 promoter, thus regulating p67(phox) expression and NADPH oxidase activity. PLAGL2 was recently found to aid in the efficient uptake of chylomicrons by intestinal lacteal vessels.
Homology Homologous to the human PLAG1 and PLAGL1 proteins.

Mutations

Note Mutation has not been reported in the PLAGL2 coding region.

Implicated in

Entity Carcinogenicity
Note PLAGL2 is an oncoprotein involved in various malignancies including lipoblastomas, hepatoblastomas, and acute myeloid leukemia. PLAGL2 expression is increased in human cancers including acute myeloid leukemia (AML). The expression is increased in 20% of human AML samples. The PLAGL2 gene can independently cooperate with CBFB- MYH11 fusion gene in leukemogenesis. AML subtype M4 with eosinophilia is associated with a chromosome 16 inversion that creates a fusion gene CBFB-MYH11, encoding CBFbeta-SMMHC fusion protein. This fusion protein inhibits the core-binding factor (CBF), resulting in a block of hematopoietic differentiation and induction of leukemia in the presence of additional mutations.
Disease Cancer; lipoblastomas, hepatoblastomas, and acute myeloid leukemia.
  

External links

Nomenclature
HugoPLAGL2
GDBPLAGL2
Entrez_GenePLAGL2  5326  pleiomorphic adenoma gene-like 2
Cards
AtlasPLAGL2ID41738ch20q11
GeneCardsPLAGL2
EnsemblPLAGL2 [Search_View]   ENSG00000126003 [Gene_View]
GenatlasPLAGL2
GeneLynxPLAGL2
eGenomePLAGL2
euGene5326
Genomic and cartography
GoldenPathPLAGL2  -  20q11.21   chr20:30243968-30259207 -  20q11.21   [Description]    (hg18-Mar_2006)
EnsemblPLAGL2 - 20q11.21 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGenePLAGL2
Gene and transcription
GenbankAF006005 [ ENTREZ ]
GenbankAK026951 [ ENTREZ ]
GenbankAK292450 [ ENTREZ ]
GenbankBC023655 [ ENTREZ ]
GenbankD83784 [ ENTREZ ]
RefSeqNM_002657 [ SRS ]    NM_002657 [ ENTREZ ]
RefSeqAC_000063 [ SRS ]    AC_000063 [ ENTREZ ]
RefSeqNC_000020 [ SRS ]    NC_000020 [ ENTREZ ]
RefSeqNT_028392 [ SRS ]    NT_028392 [ ENTREZ ]
RefSeqNW_927339 [ SRS ]    NW_927339 [ ENTREZ ]
AceViewPLAGL2 AceView - NCBI
UnigeneHs.154104 [ SRS ]    Hs.154104 [ NCBI ]     HS154104 [ spliceNest ]
Fast-db7793 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtQ9UPG8 [ SRS]    Q9UPG8 [ EXPASY ]     Q9UPG8 [ INTERPRO ]
PrositePS00028 ZINC_FINGER_C2H2_1 [ SRS ]    PS00028 ZINC_FINGER_C2H2_1 [ Expasy ]
PrositePS50157 ZINC_FINGER_C2H2_2 [ SRS ]    PS50157 ZINC_FINGER_C2H2_2 [ Expasy ]
InterproIPR007087 Znf_C2H2 [ SRS ]    IPR007087 Znf_C2H2 [ EBI ]
InterproIPR015880 Znf_C2H2-like [ SRS ]    IPR015880 Znf_C2H2-like [ EBI ]
InterproIPR013087 Znf_C2H2/integrase_DNA-bd [ SRS ]    IPR013087 Znf_C2H2/integrase_DNA-bd [ EBI ]
CluSTrQ9UPG8
PfamPF00096 zf-C2H2 [ SRS ]    PF00096 zf-C2H2 [ Sanger ]    pfam00096 [ NCBI-CDD ]
SmartSM00355 ZnF_C2H2 [EMBL]
BlocksQ9UPG8
HPRD05333
Protein Interaction databases
DIPQ9UPG8
IntActQ9UPG8
Polymorphism : SNP, mutations, diseases
OMIM604866    [ map ]   
GENECLINICS604866
SNPPLAGL2 [dbSNP-NCBI]  
SNPNM_002657 [SNP-NCI]  
SNPPLAGL2 [GeneSNPs - Utah]  PLAGL2] [HGBASE - SRS]
HAPMAPPLAGL2 [HAPMAP]  
COSMICPLAGL2 [Somatic mutation (COSMIC-CGP-Sanger)]  
HGMDPLAGL2
General knowledge
Family BrowserPLAGL2 [UCSC Family Browser]
SOURCENM_002657
SMDHs.154104
SAGEHs.154104
GOtranscription factor activity [Amigo]  transcription factor activity
GOintracellular [Amigo]  intracellular
GOnucleus [Amigo]  nucleus
GOtranscription [Amigo]  transcription
GOregulation of transcription, DNA-dependent [Amigo]  regulation of transcription, DNA-dependent
GOinduction of apoptosis [Amigo]  induction of apoptosis
GOzinc ion binding [Amigo]  zinc ion binding
GOpositive regulation of transcription from RNA polymerase II promoter [Amigo]  positive regulation of transcription from RNA polymerase II promoter
GOmetal ion binding [Amigo]  metal ion binding
PubGenePLAGL2
TreeFamPLAGL2
CTD5326 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbePLAGL2 Related clones (RZPD - Berlin)
PubMed
PubMed11 Pubmed reference(s) in LocusLink

Bibliography

Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells.
Abdollahi A, Godwin AK, Miller PD, Getts LA, Schultz DC, Taguchi T, Testa JR, Hamilton TC
Cancer research. 1997 ; 57 (10) : 2029-2034.
PMID 9158001
 
Identification of a zinc-finger gene at 6q25: a chromosomal region implicated in development of many solid tumors.
Abdollahi A, Roberts D, Godwin AK, Schultz DC, Sonoda G, Testa JR, Hamilton TC
Oncogene. 1997 ; 14 (16) : 1973-1979.
PMID 9150364
 
Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain.
Spengler D, Villalba M, Hoffmann A, Pantaloni C, Houssami S, Bockaert J, Journot L
The EMBO journal. 1997 ; 16 (10) : 2814-2825.
PMID 9184226
 
Transcriptional activation capacity of the novel PLAG family of zinc finger proteins.
Kas K, Voz ML, Hensen K, Meyen E, Van de Ven WJ
The Journal of biological chemistry. 1998 ; 273 (36) : 23026-23032.
PMID 9722527
 
PLAG1, the main translocation target in pleomorphic adenoma of the salivary glands, is a positive regulator of IGF-II.
Voz ML, Agten NS, Van de Ven WJ, Kas K
Cancer research. 2000 ; 60 (1) : 106-113.
PMID 10646861
 
Involvement of PLAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines.
Furukawa T, Adachi Y, Fujisawa J, Kambe T, Yamaguchi-Iwai Y, Sasaki R, Kuwahara J, Ikehara S, Tokunaga R, Taketani S
Oncogene. 2001 ; 20 (34) : 4718-4727.
PMID 11498794
 
The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities.
Hensen K, Van Valckenborgh IC, Kas K, Van de Ven WJ, Voz ML
Cancer research. 2002 ; 62 (5) : 1510-1517.
PMID 11888928
 
A zinc-finger protein, PLAGL2, induces the expression of a proapoptotic protein Nip3, leading to cellular apoptosis.
Mizutani A, Furukawa T, Adachi Y, Ikehara S, Taketani S
The Journal of biological chemistry. 2002 ; 277 (18) : 15851-15858.
PMID 11832486
 
Identification of genes that synergize with Cbfb-MYH11 in the pathogenesis of acute myeloid leukemia.
Castilla LH, Perrat P, Martinez NJ, Landrette SF, Keys R, Oikemus S, Flanegan J, Heilman S, Garrett L, Dutra A, Anderson S, Pihan GA, Wolff L, Liu PP
Proceedings of the National Academy of Sciences of the United States of America. 2004 ; 101 (14) : 4924-4929.
PMID 15044690
 
Repression of the Transactivating Capacity of the Oncoprotein PLAG1 by SUMOylation.
Van Dyck F, Delvaux EL, Van de Ven WJ, Chavez MV
The Journal of biological chemistry. 2004 ; 279 (34) : 36121-36131.
PMID 15208321
 
Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11.
Landrette SF, Kuo YH, Hensen K, Barjesteh van Waalwijk van Doorn-Khosrovani S, Perrat PN, Van de Ven WJ, Delwel R, Castilla LH
Blood. 2005 ; 105 (7) : 2900-2907.
PMID 15585652
 
Pleiomorphic adenoma gene-like-2, a zinc finger protein, transactivates the surfactant protein-C promoter.
Yang MC, Weissler JC, Terada LS, Deng F, Yang YS
American journal of respiratory cell and molecular biology. 2005 ; 32 (1) : 35-43.
PMID 15361364
 
Sumoylation and acetylation play opposite roles in the transactivation of PLAG1 and PLAGL2.
Zheng G, Yang YC
The Journal of biological chemistry. 2005 ; 280 (49) : 40773-40781.
PMID 16207715
 
Cbf beta-SMMHC induces distinct abnormal myeloid progenitors able to develop acute myeloid leukemia.
Kuo YH, Landrette SF, Heilman SA, Perrat PN, Garrett L, Liu PP, Le Beau MM, Kogan SC, Castilla LH
Cancer cell. 2006 ; 9 (1) : 57-68.
PMID 16413472
 
Cloning and embryonic expression of zebrafish PLAG genes.
Pendeville H, Peers B, Kas K, Voz ML
Gene expression patterns : GEP. 2006 ; 6 (3) : 267-276.
PMID 16378757
 
LOT1 (ZAC1/PLAGL1) and its family members: mechanisms and functions.
Abdollahi A
Journal of cellular physiology. 2007 ; 210 (1) : 16-25.
PMID 17063461
 
Binding of pleomorphic adenoma gene-like 2 to the tumor necrosis factor (TNF)-alpha-responsive region of the NCF2 promoter regulates p67(phox) expression and NADPH oxidase activity.
Ammons MC, Siemsen DW, Nelson-Overton LK, Quinn MT, Gauss KA
The Journal of biological chemistry. 2007 ; 282 (24) : 17941-17952.
PMID 17462995
 
PLAGL2 translocation and SP-C promoter activity--a cellular response of lung cells to hypoxia.
Guo Y, Yang MC, Weissler JC, Yang YS
Biochemical and biophysical research communications. 2007 ; 360 (3) : 659-665.
PMID 17618602
 
Tip60 modulates PLAGL2-mediated transactivation by acetylation.
Ning J, Zheng G, Yang YC
Journal of cellular biochemistry. 2008 ; 103 (3) : 730-739.
PMID 17551969
 
Loss of the PlagL2 transcription factor affects lacteal uptake of chylomicrons.
Van Dyck F, Braem CV, Chen Z, Declercq J, Deckers R, Kim BM, Ito S, Wu MK, Cohen DE, Dewerchin M, Derua R, Waelkens E, Fiette L, Roebroek A, Schuit F, Van de Ven WJ, Shivdasani RA
Cell metabolism. 2007 ; 6 (5) : 406-413.
PMID 17983586
 
PLAG1, the prototype of the PLAG gene family: versatility in tumour development (review).
Van Dyck F, Declercq J, Braem CV, Van de Ven WJ
International journal of oncology. 2007 ; 30 (4) : 765-774.
PMID 17332914
 
PLAGL2 controls the stability of Pirh2, an E3 ubiquitin ligase for p53.
Zheng G, Ning J, Yang YC
Biochemical and biophysical research communications. 2007 ; 364 (2) : 344-350.
PMID 17950244
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written01-2008Abbas Abdollahi
Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, BioLife Sciences Building, Suite 446, Temple University, 1900 North 12th Street, Philadelphia, PA 19122, USA

Citation

This paper should be referenced as such :
Abdollahi A . PLAGL2 (Pleomorphic adenoma gene-like 2). Atlas Genet Cytogenet Oncol Haematol. January 2008 .
URL : http://AtlasGeneticsOncology.org/Genes/PLAGL2ID41738ch20q11.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Wed Jul 2 08:26:02 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.